GenSight Biologics S.A.
GSGTF
$0.19
-$0.05-20.79%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -16.45M | -15.64M | -15.15M | -18.48M | -21.76M |
| Total Depreciation and Amortization | 714.20K | 925.00K | 1.15M | 1.71M | 2.27M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 616.60K | -160.40K | -937.50K | 57.90K | 1.06M |
| Change in Net Operating Assets | 6.37M | 3.57M | 946.50K | 1.15M | 1.34M |
| Cash from Operations | -8.74M | -11.30M | -13.99M | -15.56M | -17.09M |
| Capital Expenditure | 0.00 | -500.00 | -1.00K | -6.40K | -11.80K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -52.60K | -15.50K | 19.50K | 52.30K | 85.50K |
| Cash from Investing | -52.60K | -16.00K | 18.40K | 45.80K | 73.60K |
| Total Debt Issued | -- | -- | -- | 3.09M | 6.18M |
| Total Debt Repaid | -2.84M | -2.87M | -2.90M | -1.80M | -698.00K |
| Issuance of Common Stock | 3.93M | 8.96M | 14.00M | 14.27M | 14.54M |
| Repurchase of Common Stock | -5.00K | -16.00K | -27.00K | -74.00K | -121.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 638.00K | 1.55M | 2.47M | 2.07M | 1.68M |
| Cash from Financing | 1.86M | 8.22M | 14.64M | 18.98M | 23.35M |
| Foreign Exchange rate Adjustments | -312.90K | -315.20K | -317.20K | -125.50K | 71.50K |
| Miscellaneous Cash Flow Adjustments | -1.10K | -500.00 | -- | -500.00 | -1.00K |
| Net Change in Cash | -7.25M | -3.42M | 347.90K | 3.33M | 6.40M |